News | Oncology Diagnostics | January 31, 2018

Elekta and IBM Watson Health Bringing Artificial Intelligence to Oncology

Elekta to sell Watson for Oncology clinical decision support paired within Mosaiq OIS and other Elekta solutions

Elekta and IBM Watson Health Bringing Artificial Intelligence to Oncology

January 31, 2018 – Elekta announced it is collaborating with IBM Watson Health to offer Watson for Oncology with Elekta’s cancer care solutions. Under the terms of a new agreement, Elekta will sell Watson for Oncology beginning in early 2018 as a clinical decision support (CDS) solution paired within Elekta’s digital cancer care solutions, including the Mosaiq oncology information system (OIS). Elekta intends to offer both solutions in most markets around the world including the U.S., Brazil, certain major European and Asian markets, as well as India and Australia.

Cancer is responsible for one in six deaths around the world, and each year there are more than 14 million new cancer cases worldwide.(1) As healthcare providers and systems seek to enable data-driven, evidence-based cancer care, an explosion of medical information has created both challenges and opportunities to help improve quality of care. Currently, approximately 50,000 oncology research papers are published annually,(2) and by 2020 medical information is projected to double every 73 days(3), outpacing the ability of humans to keep up with the proliferation of medical knowledge.

Elekta CEO Richard Hausmann said the goal of the collaboration is to bring cutting-edge artificial intelligence (AI) technology to the cancer care continuum, including treatment planning, enabling evidence-based treatment recommendations for every patient regardless of where they are treated.

Watson for Oncology was developed by IBM in collaboration with Memorial Sloan Kettering Cancer Center (MSK) in New York. It can summarize key medical attributes of a patient, and provide information to oncologists to help them deliver treatment options based on training from MSK oncologists. Watson for Oncology ranks the treatment options, linking to peer-reviewed studies that have been curated by MSK. Watson for Oncology also provides a large corpus of medical literature for a physician to consider, drawing on more than 300 medical journals, more than 200 textbooks, and nearly 15 million pages of text to provide insights about different treatment options.

For more information: www.elekta.com, www.ibm.com/watson/health

References:

(1) World Health Organization, Cancer Fact Sheet:  http://www.who.int/mediacentre/factsheets/fs297/en/

(2) PubMed, accessed at pubmed.com

(3) Densen, Peter, Challenges and Opportunities Facing Medical Education 2011. Transactions in the American Clinical and Climatological Association. Accessed at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116346/

Related Content

Sponsored Content | Videos | Artificial Intelligence | May 25, 2018
Change Healthcare is looking at how to apply AI into enterprise imaging by using algorhythms to change data into know
News | Digital Radiography (DR) | May 25, 2018
Konica Minolta Healthcare Americas Inc. announced that two clinical studies utilizing the company’s Dynamic Digital...
Carestream DRX-Revolution Nano Mobile X-ray System Wins 2018 Australian Good Design Award
News | Digital Radiography (DR) | May 25, 2018
The Carestream DRX-Revolution Nano Mobile X-ray System, designed by Australia-based Micro-X Ltd, received the Good...
Videos | Artificial Intelligence | May 24, 2018
ITN Contributing Editor Greg Freiherr interviews Eliot Siegel, M.D., radiology professor at the University of Mar
Australia's Largest Public Health System Selects Sectra for Enterprise Imaging IT Solution
News | PACS | May 24, 2018
Australia’s NSW Health signed a Proof of Concept agreement naming Sectra as the preferred vendor for a large enterprise...
Mach7 Technologies and Client Outlook Partner on Reconstructed Enterprise PACS Solution
News | Enterprise Imaging | May 23, 2018
May 23, 2018 — Mach7 Technologies and Client Outlook announced their expanded partnership to focus on today’s prevale
Videos | Enterprise Imaging | May 22, 2018
ITN Contributing Editor Greg Freiherr interviews Kim Garriott, Principal Consultant, Logicalis
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
New Studies Highlight MRI Use for Prostate Cancer Screening and Management
News | Magnetic Resonance Imaging (MRI) | May 21, 2018
Three new studies presented at the 113th annual meeting of the American Urological Association (AUA) highlight the...
ACR Urges Stricter Adherence to Lung Cancer Screening Guidelines
News | Lung Cancer | May 21, 2018
A new statement from the American College of Radiology (ACR) asserts that provider non-compliance to lung cancer...
Overlay Init